I was going to reply but thought others would before me.
I my view Jefferies is engaged to maintain and provide a view of Neuren's current valuation.
My guess is that offers have been coming for quite some time- before Jefferies were engaged, and they are there to advise the Board on the acceptability of said offers.
Neuren have a view of our valuation, and will keep progressing not trials for all indications until that valuation is met...
The Whens and Whys of Top Biotech M&A Deals, page-69
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.13 |
Change
-0.010(0.07%) |
Mkt cap ! $1.933B | |||
| Open | High | Low | Value | Volume |
| $15.04 | $15.30 | $14.96 | $6.401M | 422.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1 | $15.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.16 | 6015 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |